NAD+ Infusion. The Backup Generator of Your Cells, What Science Really Knows in 2026.

There is a moment when many of my patients say almost the exact same words. "I'm still functioning. But I'm not burning anymore." They come to me with burnout, with Long Covid, after surgeries, after infections, or simply with the feeling that the last few years have aged them by a decade. They have already had their thyroid, hormones, vitamins, and iron checked. On paper, almost everything is normal. In real life, nothing is normal.

In this article, I want to introduce you to a molecule that works exactly in this gap. It's called NAD+, short for the long name nicotinamide adenine dinucleotide. You can think of NAD+ as a tiny helper molecule that sits inside every single cell of your body, where it constantly mediates between energy production, repair, and inflammation control. With age, its level can drop by half. And that is precisely why, in many people, four things collapse simultaneously. Energy, cellular repair, inflammation control, and the regulation of aging.

I will show you why NAD+ subjectively helps so many people, what the hard studies really say, what they don't yet say, when an infusion makes sense for you and when it doesn't, what the procedure looks like in practice, and why certain NAD+ stories on the internet should be approached with serious skepticism. And yes, by the end, also what is really behind "growing younger," "becoming more beautiful," and "cancer protection."

What NAD+ Really Is, in Simple Terms

Picture your cells as small workshops. Each cell contains between 200 and 2,000 so-called mitochondria. Mitochondria are the power plants of your cells. In these workshops, sugar and fat are burned to produce energy. For this, you need a helper molecule that carries electrons, those tiny packets of energy, back and forth. That helper is NAD+.

NAD+ exists in two states. NAD+ is the empty battery. NADH is the charged battery. When food is burned, electrons jump onto NAD+, and it becomes NADH. In the so-called respiratory chain, the final step of energy production, NADH releases the electrons again and NAD+ is created anew. This happens millions of times per second in your cells. At the end of this chain stands ATP. ATP is the actual energy molecule with which your cells pay for every single action, from heartbeat to thinking to digestion.

But that is only a fraction of the story. Because NAD+ is not just an energy helper. It is also consumed by four enzyme families, that is, four groups of tiny biological machines that co-regulate your health, your repair capacity, and your pace of aging.

Four functions, a single helper molecule. When this helper goes missing, the system fails on four fronts simultaneously. That is what makes NAD+ loss so brutal. It is never just "a little less energy." It is an entire regulatory crisis inside your cells.

Why Your NAD+ Collapses. The Pathophysiology Behind Burnout, Long Covid, and Exhaustion

If you want to understand why NAD+ therapy has any clinical justification at all, you need to understand why your NAD+ pool collapses. There are four main causes, and they almost always run in parallel.

Cause 1. Inflammaging and CD38

Inflammaging is a medical term for low-grade chronic inflammation that increases with age. With every year, with every infection, with every chronic stressor, so-called senescent cells accumulate in your tissue. You can think of these cells as zombie cells. They no longer divide, but they don't die either, and they constantly emit inflammatory signaling molecules that researchers call SASP. These signaling molecules upregulate the protein CD38 in immune scavenger cells, in the cells of your blood vessel walls, and in other tissues. CD38 is the NAD+ police that breaks NAD+ down. Camacho-Pereira and colleagues showed in 2016 that CD38 is the main cause of age-related NAD+ loss. Covarrubias and colleagues demonstrated in 2020 that senescent cells, via SASP, activate CD38 in scavenger cells and thus actively lower NAD+ in tissue.

Cause 2. PARP1 Hyperactivation

Chronic oxidative stress, that is, the burden on cells from free radicals, UV radiation, toxins, alcohol, sleep deprivation, or reactivated viruses, causes constant small damage to your DNA. PARP1, the repair enzyme, kicks in every time. But the price is high. Under sustained PARP1 activation, the NAD+ supply in the cell can collapse by up to 80 percent. Sirtuins, which should be dampening inflammation, then have no substrate left. The mitochondria slip into a second crisis.

Cause 3. NAMPT Decline, the Drying Well

NAMPT is an enzyme that rebuilds fresh NAD+ from the metabolic byproduct nicotinamide, a kind of recycling plant inside the cell. This recycling pathway is called the salvage pathway. From the age of 40 onward, NAMPT activity drops noticeably in many tissues. So you lose two things simultaneously. More NAD+ consumption through CD38 and PARP1, less NAD+ production through declining NAMPT.

Cause 4. Mitochondrial Dysfunction. The Key Finding in Burnout, Long Covid, and Chronic Fatigue Syndrome

Chronic fatigue syndrome, known in the literature as ME/CFS, is biochemically very similar to what we find in Long Covid and severe burnout. A 2025 paper in Cell Reports Medicine showed in these patients a reduced ratio of ATP to its energy-poor sibling ADP, that is, less charged battery per cell. It also showed a shift away from efficient energy generation in the mitochondria toward an emergency mode called glycolysis, which runs without oxygen but yields far less energy. And it showed a disturbance of the kynurenine pathway, an important metabolic route along which the amino acid tryptophan is converted into NAD+. A review in Physiology 2025 summarizes that the protein WASF3 directly destabilizes the components of the respiratory chain. This is the cellular truth behind burnout. It is not "all in your head." It is a real energy crisis in your mitochondria.

Burnout, Retold. What Actually Happens in Your Cells

When I work with burnout patients, my first picture is often that of an overloaded control center. The HPA axis, that is, the stress axis between the hypothalamus and pituitary in the brain and the adrenals, the small hormone glands above your kidneys, runs in the red for months or years. Cortisol, the most important stress hormone, is either too high in the morning or, in later phases, paradoxically lowered. Sleep becomes shallow. Digestion slows. The vagus, your central calming nerve that down-regulates breathing, heart rate, and digestion, retreats. And in the cells, the following happens.

• Mitochondria reduce their number and function. Studies in burnout patients show reduced energy production in immune cells.
• The NAD+ pool drops through chronic activation of PARP1 and CD38.
• Sirtuin activity collapses. SIRT1 can no longer switch off the inflammation switch NF-kappa B. Low-grade inflammation rises.
• Tryptophan, an amino acid from your food and a precursor of serotonin, the most important mood neurotransmitter, is redirected under stress into the kynurenine pathway. Instead of happiness, your body produces inflammatory metabolites such as quinolinic acid, which place an additional burden on the brain.
• The brain's nightly cleaning system, the glymphatic system, becomes sluggish. Sleep architecture suffers. Brain fog, that feeling of thinking as if under a glass dome, becomes a clinical reality.

NAD+ is interesting in precisely this constellation because it can act at several points simultaneously. It supplies substrate for the respiratory chain, reactivates the sirtuins, dampens the inflammation switch NF-kappa B indirectly via SIRT1, and it supports the formation of NADPH, a variant that regenerates the body's most important antioxidant, glutathione, and in this way neutralizes free radicals. NAD+ is a multitool. That is precisely its clinical appeal.

What the Studies Actually Show. A Differentiated Evidence Table 2026

This is the most honest part. I divide the evidence into three tiers so you can judge for yourself what is solidly supported and what is promising but still thin.

The Key Studies in Detail

Heart and Circulation. Why NAD+ Is So Compelling Cardiologically

The heart is the body's largest energy consumer. It beats about 100,000 times per day, turning over many times its own weight in energy currency. A healthy heart depends on intact mitochondria, that is, fully functional power plants. In heart failure, these mitochondria are weakened. They produce less ATP, that is, less energy per second, and more oxygen radicals, that is, harmful metabolic byproducts. This is exactly where NAD+ comes in.

This does not mean NAD+ replaces the established cardiac medications, that is, statins for cholesterol lowering, ACE inhibitors and beta blockers for blood pressure, or the newer SGLT2 inhibitors for heart failure. But it can be an additional axis, especially in patients with metabolically driven heart disease who continue to suffer despite standard therapy. The combination of NAD+ supplementation and standard cardiac therapy is a sensible integrative strategy, always in coordination with the treating cardiologist.

Brain and Mood. When Thinking Becomes Clear Again

The human brain accounts for about 2 percent of body weight but consumes 20 percent of total energy. It is by far the most energy-hungry organ. When the mitochondria in nerve cells come under pressure, concentration, mood, sleep, and stress resilience all suffer. NAD+ intervenes here at multiple points.

Brain Fog Is Not a Made-Up Problem

Imaging studies in Long Covid and chronic fatigue syndrome show reduced glucose metabolism in the front regions of the brain that are responsible for concentration and planning. This is the cellular basis of the subjective fog in the head. NAD+ activates the respiratory chain in nerve cells and their support cells, the astrocytes, via the protective enzyme SIRT3. In the NADPARK study, the NAD+ level was measured directly in the living brain for the first time, using a specialized form of magnetic resonance, phosphorus MR spectroscopy. After NR administration, the level rose measurably. Patients with the strongest rise in the brain showed at the same time a measurable improvement on the UPDRS score, the standard scale for the severity of Parkinson's symptoms.

Mood and Drive

SIRT1 also acts on switching points in the dopaminergic pathway, that is, the nerve pathways that work with the messenger dopamine and control drive, joy, and motivation. Animal studies show that NAD+ deficiency in the front of the brain triggers depressive behavior. In humans, the evidence is more indirect, but consistent. In the 2025 Long Covid study, depressive symptoms improved significantly after 10 weeks of NR compared with baseline.

Neurodegeneration

In Parkinson's, Alzheimer's, and the motor neuron disease ALS, NAD+ deficiency is reproducibly documented. The NOPARK Phase 2 study in 400 Parkinson's patients is ongoing. First results are expected in 2026. The hypothesis is that NAD+ supplementation can slow the course of the disease. This is not proven. But the mechanistic plausibility is strong.

Tumor and Cancer. Here Things Get Delicate

NAD+ and cancer is one of the most exciting and at the same time most sensitive topics. Two extreme positions circulate online. Some claim NAD+ protects against cancer. Others warn that NAD+ feeds tumors. The truth is more complex, and honestly, two-edged.

What Argues for Protection in Healthy People

NAD+ activates the DNA repair machinery, that is, PARP1 and the sirtuins. Intact DNA repair reduces the accumulation of mutations that may lead to cancer in the long run. Nicotinamide, a precursor of NAD+, significantly reduced the recurrence of non-melanoma skin cancers in high-risk patients in a large randomized trial. That was the ONTRAC study in 2015. A systematic review on skin health also showed effects on UV-induced damage.

What Argues for Caution in the Tumor Case

Tumor cells have a massively increased NAD+ demand. They use it for their own rapid proliferation. There is even an entire class of cancer drugs in clinical development, so-called NAMPT inhibitors, which do exactly the opposite of NAD+ therapy. They block the NAD+ supply in tumor cells in order to halt their growth. For exactly this reason, NAD+ supplementation is contraindicated in active cancer disease, except in close coordination with oncology, that is, the medical specialty for cancer.

The Important Differentiation

NAD+ as cancer protection in the healthy is a plausible hypothesis with positive signals from the ONTRAC study and mechanistic plausibility. NAD+ as a cancer booster in the tumor case is also a realistic scenario based on tumor biology. The difference is the context, that is, the state of the body into which the molecule is given.

Longevity. What We Really Know About Biological Age and NAD+

Longevity is the buzzword of recent years. Behind the term lies a very concrete question. Can you extend the time you spend in good health, the so-called healthspan? And can you become biologically younger, measured with modern blood-test markers such as the epigenetic clock or telomere length?

What Are Biological Age Markers

What Can NAD+ Deliver on This Axis

At the level of biological mechanisms, the plausibility is strong. NAD+ activates sirtuins, which in turn alter chemical markings on the DNA and so influence gene expression and methylation patterns. NAD+ supports PARP1 repair, which slows the shortening of telomeres. NAD+ dampens inflammaging, which lowers the inflammation values hs-CRP and IL-6. In animal studies, NAD+ supplementation extends lifespan and improves epigenetic markers. In humans, large studies of this kind are still being built. First observational studies suggest that NMN as an oral precursor can improve inflammation markers and markers of vascular aging.

What We Don't Yet Know

There is currently no large endpoint RCT showing that NAD+ precursors measurably reverse the epigenetic clock in a broad population. In smaller studies there have been signals, in others none. We are in an exciting phase in which the concept is biologically very plausible, but the number of hard clinical endpoints is still growing.

Becoming More Beautiful. Skin, Hair, Collagen. What's Possible, What Isn't

Here is the honest layout. Two areas have data, one does not yet.

Hair. There Is First Real Data

The 2025 Cosmetics study from Tokyo is small, only 15 women, but methodologically clean. 500 mg of NMN over 12 weeks. The density of growing hairs in the anagen phase, that is, the active growth phase of a hair, rose by 57 percent. The density of fully developed terminal hairs rose by 71 percent. Hair thickness increased. Mechanistically, that fits with what we know about NAD+ and stem cells, that is, the mother cells from which new cells emerge, in the growth environment of the hair follicle. SIRT1 and SIRT3 protect these stem cells, NAD+ supplies the energy for the anagen phase.

Skin. Mechanism Strong, Clinical Human Data Limited

In mouse studies and cell cultures, NMN shows clear effects on the skin barrier, on collagen type I, the most important structural protein of the skin which gives it firmness, on UV protection, and on wound healing. A 2025 paper showed improved skin structure and reduced wrinkle formation in mice. In humans, large studies still missing that cleanly measure purely cosmetic endpoints such as wrinkles and elasticity. What we do have are studies on nicotinamide, a close relative. In the ONTRAC study, nicotinamide reduced skin cancer incidence and improved markers of the skin barrier.

Collagen and Connective Tissue

SIRT1 regulates the activity of fibroblasts, the connective tissue cells that produce collagen. NAD+ is an additionally required helper molecule in this reaction. Under oxidative stress, one of the main causes of collagen breakdown, NAD+ has a supportive effect. Direct clinical studies on wrinkle reduction are missing.

Metabolism, Weight, Insulin

Yoshino and colleagues showed in a paper published in Science in 2021 that NMN can increase the insulin sensitivity of muscle cells in prediabetic women, that is, women with a precursor stage of type 2 diabetes, by about 25 percent. Insulin sensitivity describes how well your cells respond to the hormone insulin and take up sugar from the blood. The effects on fasting blood sugar and HbA1c, the long-term blood sugar value over the past three months, were mixed in follow-up studies. That fits with what we know mechanistically. NAD+ activates SIRT1 and SIRT3, which makes the mitochondria more efficient. It improves the utilization of free fatty acids, that is, the fat building blocks in the blood. It can contribute to metabolic reorganization in fatty liver, that is, a pathological accumulation of fat in the liver.

NAD+ is not a weight-loss drug. But it can be a building block in a holistic program for metabolically burdened patients, a program made of time-structured nutrition, strength training, sleep hygiene, and stress regulation.

Immune System and Chronic Inflammation

The protective enzyme SIRT1 deacetylates, that is, removes a chemical marking from, a component of NF-kappa B. NF-kappa B is the central switch for inflammation genes in the cell nucleus. By resetting this switch, SIRT1 dampens the production of inflammatory messengers. Without sufficient NAD+, SIRT1 cannot do this. NF-kappa B runs unchecked, and the inflammation values IL-6, TNF-alpha, and CRP rise. This is the molecular basis of inflammaging.

Clinically, the Elhassan study from 2019 shows that oral NR over 21 days can lower IL-6 and TNF-alpha and upregulate the activity of inflammation-suppressing genes in muscle. In the Werner syndrome crossover RCT in 2025, alongside vessels and skin, markers of chronic inflammation also improved.

When Does an NAD+ Infusion Make Clinical Sense

I do not go by hype indications. I go by pathophysiology and individual situation. Here are the typical profiles in which I most frequently see a clinically relevant effect.

High Plausibility

• Post-Covid syndrome with dominant exhaustion and brain fog
• Burnout after a prolonged high-stress phase, with classic mitochondrial markers
• Reactivated chronic infections, such as a flare-up of the Epstein-Barr virus, which many people once experienced as glandular fever, with persistent exhaustion
• Recovery phase after surgery, chemotherapy, severe illness. In the oncological context only in close coordination with cancer medicine
• Early neurodegenerative burden with subjective sense of cognitive decline
• Heart failure adjunctive therapy in coordination with cardiology
• Werner syndrome or other models of accelerated aging
• Chronic inflammatory constellations with elevated hs-CRP and IL-6

Moderate Plausibility

• Targeted longevity approach in people with objective cellular-aging markers
• Recovery in performance-oriented people with overdosed loading
• Improvement of skin and hair as a secondary effect within a broader program
• ADHD-like exhaustion with a dominant mitochondrial component

Of Little Use or Contraindicated

• Pure lifestyle boosting without indication and without diagnostics
• Active cancer disease without clearance from the treating oncologist
• Pregnancy and breastfeeding. Insufficient data
• Severe kidney insufficiency or liver disease
• Uncontrolled high blood pressure, acute cardiac decompensation
• Known severe niacin intolerance or severe allergic reactions in the medical history
• Certain chemotherapies or immunosuppressants. To be evaluated case by case

What the Process Looks Like in My Practice

I will describe the complete path, from the first history-taking, that is, the initial medical conversation in which your medical history is recorded, through to the maintenance phase, so you know exactly what to expect.

Safety, Side Effects, What You Need to Know

NAD+ is an active molecule. That is its appeal and its risk in equal measure. In the right hands, with slow dosing and medical supervision, it is well controllable. Here is the honest overview.

What NAD+ CANNOT Do. The Honest Differentiation

• NAD+ is not an antidepressant. In moderate to severe depression, psychotherapy and where indicated pharmacotherapy remain the first line.
• NAD+ does not replace clean thyroid diagnostics, evaluation of nighttime breathing pauses, or hormone substitution.
• NAD+ does not make you young. It can modulate cellular aging processes. It is not a fountain of youth.
• For mere mild fatigue, lifestyle plus oral NAD+ precursors are usually enough. An infusion is intended for situations with a real burden of mitochondrial dysfunction and inflammaging.
• NAD+ does not work without a lifestyle foundation. Sleeping poorly, smoking, drinking heavily, eating industrial food, barely moving. Those who keep all of that in place will not rescue their mitochondria with NAD+ either.
• NAD+ is not a guarantee against cancer. In the active tumor case it is contraindicated. In the healthy, there are plausible protective hypotheses.

My Medical Conclusion

NAD+ is not a hype molecule. But it is also not a miracle drug. It is one of the most well-founded cellular tools I know in my practice when the indication is right. I always practice according to the same principles.

• Understanding before prescribing. You should know why NAD+ makes sense in your situation, or why it doesn't.
• Diagnostics before infusion. No NAD+ therapy without history-taking, lab work, and an individual concept.
• Slow, safe, medically supervised. At least 2 hours. Never as an express drip.
• In an overall context. NAD+ is one building block in a plan made of sleep, nutrition, exercise, stress regulation, hormone balance, and micronutrients.
• Differentiated expectations. Not every person benefits equally. We discuss this openly.

If you have been feeling for months or years that your batteries no longer charge properly, and if classic diagnostics do find some abnormalities but no full explanation, it is worth taking the mitochondrial level seriously. NAD+ is one of the most powerful levers we have at this level. It is not for everyone. But for those for whom it fits, it can make a real difference. Not because I claim so, but because the physiology stands behind it.

Frequently Asked Questions

This article does not replace medical advice. NAD+ therapies belong in qualified medical hands, with individual history-taking, diagnostics, and follow-up. As of April 2026.